Loading...
HSChapter 30
U.S. imports of extracts of glands or other organs or secretions (HS 300120) totaled $185K in April 2026, traded with 15 countries.
Extracts of Glands or Other Organs or Secretions imports of $185K in April 2026 ran 81% below the year-to-date monthly average of $972K.
Last updated: April 2026 dataGlandular and organ extracts — including those derived from pituitary, adrenal, thyroid, and other endocrine tissues — serve as raw materials for pharmaceutical manufacturing, diagnostic reagents, and research applications, and their import is subject to FDA review as biological source materials. All imports under the single 10-digit line 3001200000 may also require USDA APHIS review if derived from animal species subject to disease-related import restrictions. Spain and Japan are the leading suppliers to the US market, with Denmark also a significant source, reflecting strong veterinary and pharmaceutical processing industries in those countries. Admissibility can be complex; importers are advised to consult a licensed customs broker and confirm applicable FDA and APHIS requirements before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
FDA reviews these materials as biological source substances when intended for pharmaceutical or diagnostic use, while USDA APHIS may impose additional restrictions based on the species of origin and the disease status of the exporting country. Importers should verify both agencies' requirements before arranging shipment, as clearance from one agency does not substitute for the other.
Species of origin does not change the HTS classification — all gland and organ extracts fall under 3001200000 regardless of whether they are bovine, porcine, or ovine — but it significantly affects admissibility. Extracts from species or countries subject to APHIS disease-related import restrictions (e.g., foot-and-mouth disease zones) may require additional permits or be refused entry entirely.
Supplier Network
Get discovered by U.S. importers searching for HS 300120 — Extracts of Glands or Other Organs or Secretions. Be the first supplier listed.
| Country | Imports | Exports | Balance |
|---|---|---|---|
| KOREA, SOUTH | -- | $1.1M | +$1.1M |
| CANADA | -- | $435K | +$435K |
| MEXICO | -- | $434K | +$434K |
| UNITED KINGDOM | $41K | $392K | +$350K |
| SWITZERLAND | -- | $385K | +$385K |
Monthly import values over time
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % |
|---|---|---|---|
| 3001200000 | EXTRACTS OF GLANDS OR OTHER ORGS OR SECRETIONS | $185K | -- |
EXTRACTS OF GLANDS OR OTHER ORGS OR SECRETIONS
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3001200000 | EXTRACTS OF GLANDS OR OTHER ORGS OR SECRETIONS | $4.5M |
EXTRACTS OF GLANDS OR OTHER ORGS OR SECRETIONS
71.5K kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Ohio | -- | $2.5M | +$2.5M |
| California | $26K | $557K | +$531K |
| Pennsylvania | $142K | $153K | +$11K |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| NEW ORLEANS, LA | $6K | $1.8M | +$1.8M |
| ANCHORAGE, AK | -- | $658K | +$658K |
| NEWARK, NJ | -- | $357K | +$357K |